APOE polymorphism and diabetic nephropathy.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 24026386)

Published in Clin Exp Nephrol on September 13, 2013

Authors

Shin-ichi Araki1

Author Affiliations

1: Department of Medicine, Shiga University of Medical Science, Seta, Otsu, Shiga, 520-2192, Japan, araki@belle.shiga-med.ac.jp.

Articles cited by this

Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 51.42

Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet (2000) 6.61

Genetic associations with human longevity at the APOE and ACE loci. Nat Genet (1994) 4.17

Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol (2007) 2.03

Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int (2002) 1.62

Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia (2010) 1.60

An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial (2012) 1.37

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. Clin Genet (1995) 1.00

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis (1998) 0.96

Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes (1998) 0.95

Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet (2006) 0.95

APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes (2000) 0.92

Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Mol Biol Rep (2010) 0.91

Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients. Diabetes Care (1998) 0.90

Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis (1994) 0.90

Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant (1999) 0.84

Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes. Am J Nephrol (2011) 0.82

APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Diabetes Care (2003) 0.82

Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem (2003) 0.82

The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy. J Endocrinol Invest (2009) 0.82

Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism. Transl Res (2008) 0.81

Apo E gene polymorphism on development of diabetic nephropathy. Cell Biochem Funct (2007) 0.80

Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group. Nephrol Dial Transplant (2000) 0.79

Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol (2002) 0.79

ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM? Nephrol Dial Transplant (1998) 0.77

Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients. Diabetes Res Clin Pract (2007) 0.75

Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients. Diabetologia (2000) 0.75